TAICHUNG, Taiwan, Dec. 19, 2022 /PRNewswire/ — SURGLASSES introduced at the moment that Caduceus S AR Backbone Navigation System has acquired 510(ok) clearance from the U.S. Food and Drug Administration and is able to launch its merchandise into the US market within the first quarter of 2023. Caduceus S is an augmented actuality spine navigation system that may require solely few-shots of C-arm pictures to equip the surgeons with AR and pre-surgical planning with trajectories for spine surgical procedure.
Caduceus S is an progressive medical know-how with AR has supposed use for use within the advanced spine surgical procedures. The system is designed to permit surgeons to superimpose the 3D spinal anatomy on a affected person throughout surgical procedures. It geared up with a number of trackers and shows preoperative deliberate trajectories through 3D AR head mounted show.
Dr. Wang, Min – Liang, CEO and founding father of Taiwan Most important Orthopaedic Biotechnology Co. Ltd., (SURGLASSES) acknowledged “Caduceus S is the cutting-edge know-how that may improve the spine surgical procedures accuracy and resolve the complexities of the spine surgical procedures surgeons face through the surgical procedure”. Including to it, “Bearing in mind the small/midsize hospitals and clinics which have restricted sources, Caduceus S Backbone Navigation System proves to be a significant useful resource for the surgeons for spine surgical procedure”, says Dr. Wang, Min-Liang.
Caduceus S is supplied with a clear head mounted show to allow the surgeons to have projections from the navigation system into the HMD and on the identical time have 100% discipline view of the affected person. Enabling the surgeons to have concentrate on to the sufferers reasonably than turning the top to look into the exterior screens positioned within the surgical theaters.
“Augmented Actuality know-how within the Backbone surgical procedure goes to be a turning level because it considerably results the accuracy and effectivity in doing advanced surgical procedures and putting implants. Caduceus S might be a recreation altering tools with out altering the workflow of the surgical theaters” added Dr. Wang, Min – Liang.
Caduceus S has acquired its Taiwan FDA (TFDA) clearance in August 2022 and is getting used into the surgical procedures in Taiwan since. Outcomes from utilizing the Caduceus S revealed 98.2% accuracy utilizing the Heary (thoracic) and Gertzbein (lumbar) scales. The corporate launched the first-in-human surgical procedure of its Caduceus S Backbone system in October 2022 in Taiwan for a scoliosis case with 58。Curvature.
Taiwan Most important Orthopaedic Biotechnology Co. Ltd. (SURGLASSES) pioneer within the medical know-how primarily based in Taiwan is a rising biotechnology firm specializing in bringing new and progressive applied sciences to the well being care sector. The imaginative and prescient and mission of SURGLASSES is to counterpoint the healthcare system with progressive gadgets of which Caduceus S is just the start.